학술논문
Efficacy of bone resorption inhibitors (BRI) plus abiraterone acetate plus prednisone (AA) vs. AA alone as first-line therapy for men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) in an international multicenter hospital-based registry.
Document Type
Journal
Author
Francini, Edoardo; Montagnani, Francesco; Vitale, Nuzzo Pier; Alimohamed, Nimira S.; Candilejo, Irene Moreno; Rosellini, Pietro; Gonzalez-Velez, Miguel; Rubio, Jaime; Zhang, Li; Shaw, Grace; Crivelli, Francesca; Petrioli, Roberto; Bengala, Carmelo; Francini, Guido; Foncillas, Jesus Garcia; Bryce, Alan Haruo; Sweeney, Christopher; Harshman, Lauren Christine; Lee-Ying, Richard; Heng, Daniel Yick Chin
Source
Subject
Language
English
ISSN
15277755